Seeking Alpha analysts discuss the impact of Trump's new 10-12.5% tariffs on the EU-US trade deal. Bowman highlights potential exemptions for pharmaceuticals and auto parts, affecting firms like Novo Nordisk and Bayer. Catone warns that tariffs are negative for the global economy, noting investor skepticism and a shift in market focus to Middle East conflicts. Socci notes the EU's 15% rate is locked in under EU law, while US ratification remains pending, with December 31 being a key deadline for metal tariff reductions.